Corcept Therapeutics | CORT - EPS Earnings Per Share

Stock Price
56.37
Daily Change
-1.93 -3.31%
Monthly
28.23%
Yearly
-24.92%
Q2 Forecast
55.24

Corcept Therapeutics reported $-0.3 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 -0.30 -0.11 0.17 Apr/30
FY2025Q4 Dec/2025 0.20 0.38 0.26 Feb/24
FY2025Q3 Sep/2025 0.16 0.17 0.41 Nov/04
FY2025Q2 Jun/2025 0.29 0.38 0.32 Jul/31
FY2025Q1 Mar/2025 0.17 0.15 0.25 May/05




Eps Change Date
Acadia Pharmaceuticals USD 0.02 1.58 Mar/2026
Alaunos Therapeutics USD -0.53 0.08 Sep/2025
ANI Pharmaceuticals USD 2.05 0.28 Mar/2026
Ardelyx USD -0.15 0.15 Mar/2026
Assertio Holdings USD -0.03 0.01 Sep/2024
Aurora Cannabis CAD -0.64 0.36 Dec/2025
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Canopy Growth CAD -0.05 0.03 Dec/2025
Corcept Therapeutics USD -0.3 0.5 Mar/2026
Eli Lilly USD 8.55 1.01 Mar/2026
Esperion Therapeutics USD 0.26 0.42 Dec/2025
J&J USD 2.7 0.24 Mar/2026
Knight Therapeutics CAD 0.13 0.22 Mar/2026
Lexicon Pharmaceuticals USD -0.04 0.01 Dec/2025
Merck USD -1.28 3.32 Mar/2026
Nektar Therapeutics USD -1.35 1.17 Dec/2025
Novartis USD 1.99 0.04 Mar/2026
Novartis USD 1.99 0.45 Mar/2026
Omeros USD -1.12 0.37 Jun/2024
Pacira USD 0.6 0.54 Mar/2026
Pfizer USD 0.75 0.09 Mar/2026
Supernus Pharmaceuticals USD 0.6 0.67 Mar/2026
TG Therapeutics USD 0.12 0.02 Mar/2026